Literature DB >> 15546869

Roles of conserved proline and glycosyltransferase motifs of EmbC in biosynthesis of lipoarabinomannan.

Stefan Berg1, James Starbuck, Jordi B Torrelles, Varalakshmi D Vissa, Dean C Crick, Delphi Chatterjee, Patrick J Brennan.   

Abstract

D-Arabinans, composed of D-arabinofuranose (D-Araf), dominate the structure of mycobacterial cell walls in two settings, as part of lipoarabinomannan (LAM) and arabinogalactan, each with markedly different structures and functions. Little is known of the complexity of their biosynthesis. beta-D-Arabinofuranosyl-1-monophosphoryldecaprenol is the only known sugar donor. EmbA, EmbB, and EmbC, products of the paralogous genes embA, embB, and embC, the sites of resistance to the anti-tuberculosis drug ethambutol (EMB), are the only known implicated enzymes. EmbA and -B apparently contribute to the synthesis of arabinogalactan, whereas EmbC is reserved for the synthesis of LAM. The Emb proteins show no overall similarity to any known proteins beyond Mycobacterium and related genera. However, functional motifs, equivalent to a proline-rich motif of several bacterial polysaccharide co-polymerases and a superfamily of glycosyltransferases, were found. Site-directed mutagenesis in glycosyltransferase superfamily C resulted in complete ablation of LAM synthesis. Point mutations in three amino acids of the proline motif of EmbC resulted in marked reduction of LAM-arabinan synthesis and accumulation of an unknown intermediate and of the known precursor lipomannan. Yet the pattern of the differently linked d-Araf units observed in wild type LAM-arabinan was largely retained in the proline motif mutants. The results allow for the presentation of a unique model of arabinan synthesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15546869     DOI: 10.1074/jbc.M411418200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Biosynthesis of mycobacterial lipoarabinomannan: role of a branching mannosyltransferase.

Authors:  Devinder Kaur; Stefan Berg; Premkumar Dinadayala; Brigitte Gicquel; Delphi Chatterjee; Michael R McNeil; Varalakshmi D Vissa; Dean C Crick; Mary Jackson; Patrick J Brennan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

2.  The immunomodulatory lipoglycans, lipoarabinomannan and lipomannan, are exposed at the mycobacterial cell surface.

Authors:  Sylvain Pitarque; Gérald Larrouy-Maumus; Bruno Payré; Mary Jackson; Germain Puzo; Jérôme Nigou
Journal:  Tuberculosis (Edinb)       Date:  2008-06-09       Impact factor: 3.131

Review 3.  The Mycobacterial Cell Wall--Peptidoglycan and Arabinogalactan.

Authors:  Luke J Alderwick; James Harrison; Georgina S Lloyd; Helen L Birch
Journal:  Cold Spring Harb Perspect Med       Date:  2015-03-27       Impact factor: 6.915

4.  Disruption of the SucT acyltransferase in Mycobacterium smegmatis abrogates succinylation of cell envelope polysaccharides.

Authors:  Zuzana Palčeková; Shiva K Angala; Juan Manuel Belardinelli; Haig A Eskandarian; Maju Joe; Richard Brunton; Christopher Rithner; Victoria Jones; Jérôme Nigou; Todd L Lowary; Martine Gilleron; Michael McNeil; Mary Jackson
Journal:  J Biol Chem       Date:  2019-05-20       Impact factor: 5.157

5.  Mutation at embB codon 306, a potential marker for the identification of multidrug resistance associated with ethambutol in Mycobacterium tuberculosis.

Authors:  Betzaida Cuevas-Córdoba; Dulce María Juárez-Eusebio; Raquel Almaraz-Velasco; Raquel Muñiz-Salazar; Rafael Laniado-Laborin; Roberto Zenteno-Cuevas
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

6.  Identification of Mycobacterium tuberculosis clinical isolates with altered phagocytosis by human macrophages due to a truncated lipoarabinomannan.

Authors:  Jordi B Torrelles; Rose Knaup; Avina Kolareth; Tatiana Slepushkina; Thomas M Kaufman; Peter Kang; Preston J Hill; Patrick J Brennan; Delphi Chatterjee; John T Belisle; James M Musser; Larry S Schlesinger
Journal:  J Biol Chem       Date:  2008-09-10       Impact factor: 5.157

7.  The critical role of embC in Mycobacterium tuberculosis.

Authors:  Renan Goude; Anita G Amin; Delphi Chatterjee; Tanya Parish
Journal:  J Bacteriol       Date:  2008-04-18       Impact factor: 3.490

8.  AftD, a novel essential arabinofuranosyltransferase from mycobacteria.

Authors:  Henrieta Skovierová; Gérald Larrouy-Maumus; Jian Zhang; Devinder Kaur; Nathalie Barilone; Jana Korduláková; Martine Gilleron; Stéphanie Guadagnini; Martina Belanová; Marie-Christine Prevost; Brigitte Gicquel; Germain Puzo; Delphi Chatterjee; Patrick J Brennan; Jérôme Nigou; Mary Jackson
Journal:  Glycobiology       Date:  2009-08-04       Impact factor: 4.313

Review 9.  Targeting the mycobacterial envelope for tuberculosis drug development.

Authors:  Lorenza Favrot; Donald R Ronning
Journal:  Expert Rev Anti Infect Ther       Date:  2012-09       Impact factor: 5.091

10.  Structural characterization of a partially arabinosylated lipoarabinomannan variant isolated from a Corynebacterium glutamicum ubiA mutant.

Authors:  Raju Venkata Veera Tatituri; Luke J Alderwick; Arun K Mishra; Jerome Nigou; Martine Gilleron; Karin Krumbach; Paul Hitchen; Assunta Giordano; Howard R Morris; Anne Dell; Lothar Eggeling; Gurdyal S Besra
Journal:  Microbiology (Reading)       Date:  2007-08       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.